The Pharma Chronicles
tales from the sharp edge
Chrys Muirhead Writes
Who Pays This Doctor?
Friday, 19 August 2016
'No “breakthrough” in Alzheimer’s disease' Aug16 #BMJ #LMTX #TauRx
No “breakthrough” in Alzheimer’s disease
' BMJ Feature
The trial results were disappointing so why did some of the media call the drug LMTX revolutionary?
Jacqui Wise journalist, London, UK
BMJ 2016;354:i4474 (Published 16 August 2016)
Share to Twitter
Share to Facebook
Share to Pinterest
Prof Claude Wischik; Aberdeen University
Tau Therapeutics Aberdeen